Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rochester, Minnesota 55905


Purpose:

The primary purpose of this study is to evaluate the safety profile and tolerability of single oral doses of BMS-650032 in subjects with chronic hepatitis C infection


Criteria:

Inclusion Criteria: - Chronically infected with HCV genotype 1 - Treatment naive or treatment non-responders or treatment intolerant - HCV RNA viral load of ≥10*5 IU/mL - BMI 18 to 35kg/m² Exclusion Criteria: - Any significant acute or chronic medical illness which is not stable or is not controlled with medication and not consistent with HCV infection - Major surgery within 4 weeks of study drug administration and any gastrointestinal surgery that could impact the absorption of study drug - Co-infection with HIV or HBV - Women of childbearing potential


NCT ID:

NCT00559247


Primary Contact:

Study Director
Bristol-Myers Squibb
Bristol-Myers Squibb


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota 55905
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.